Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells.
R
R
Ganapathi
A
A
Yen
D
D
Grabowski
H
H
Schmidt
R
R
Turinic
R
R
Valenzuela
D000818:Animals; D002453:Cell Cycle / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D003630:Daunorubicin / Q000494:pharmacology*; D004317:Doxorubicin / Q000494:pharmacology*; D004351:Drug Resistance; D007941:Leukemia P388 / Q000473:pathology*; D007942:Leukemia, Experimental / Q000473:pathology*; D051379:Mice; D013997:Time Factors; D014268:Trifluoperazine / Q000494:pharmacology*
D014268:Trifluoperazine; D004317:Doxorubicin; D003630:Daunorubicin